Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection.
Musvosvi, M; Huang, H; Wang, C; Xia, Q; Rozot, V; Krishnan, A; Acs, P; Cheruku, A; Obermoser, G; Leslie, A; Behar, SM; Hanekom, WA; Bilek, N; Fisher, M; Kaufmann, SH E; Walzl, G; Hatherill, M; Davis, MM; Scriba, TJ; Adolescent Cohort Study team,; GC6-74 Consortium,;
2023
Nature medicine, (2023).29 1 10.1038/s41591-022-02110-9.
Predictive performance of interferon-gamma release assays and the tuberculin skin test for incident tuberculosis: an individual participant data meta-analysis.
Hamada, Y; Gupta, RK; Quartagno, M; Izzard, A; Acuna-Villaorduna, C; Altet, N; Diel, R; Dominguez, J; FLOYD, S; Gupta, A; Huerga, H; Jones-López, EC; Kinikar, A; Lange, C; Van Leth, F; Liu, Q; Lu, W; Lu, P; Rueda, IL; Martinez, L; Mbandi, SK; Muñoz, L; Padilla, ES; Paradkar, M; Scriba, T; ... Rangaka, MX.
2023
EClinicalMedicine, (2023).56, 10.1016/j.eclinm.2022.101815.
Invited expert on the topic of M. tuberculosis transmission, the concept of 'infection potential'/ 'infectiousness'.
KHAN, P;
2023
(2023).
Diagnosing tuberculosis: evidence on cost of diagnostic tests from low- and middle-income countries.
Singh, MP; Indravudh, P; Basille, F; Cohen, T; Menzies, N; VASSALL, A; SWEENEY, S;
2023
(2023).
Transmission pathways across the spectrum of TB disease – how much transmission are we missing?.
McCaffrey, T; RICHARDS, A; Emery, J; HOUBEN, R; Horton, K;
2023
(2023).
Estimated reductions in TB prevalence following population-wide screening.
RICHARDS, A; Horton, K; MCCREESH, N; HOUBEN, R;
2023
(2023).
TBProfiler for automated calling of the association with drug resistance of variants in Mycobacterium tuberculosis.
Verboven, L; PHELAN, J; Heupink, TH; Van Rie, A;
2022
PloS One, (2022).17 12 10.1371/journal.pone.0279644.
A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis.
NYANG'WA, B-T; Berry, C; Kazounis, E; Motta, I; Parpieva, N; Tigay, Z; Solodovnikova, V; Liverko, I; Moodliar, R; DODD, M; Ngubane, N; Rassool, M; McHugh, TD; Spigelman, M; MOORE, DA J; Ritmeijer, K; Du Cros, P; FIELDING, K; TB-PRACTECAL Study Collaborators,;
2022
New England Journal of Medicine, (2022).387 25 10.1056/NEJMoa2117166.
Dataset: Cash transfer project.
TIMIRE, C; Sandy, C; FERRAND, RA; Mubau, R; Shiri, P; Mbiriyawanda, O; Mbiba, F; HOUBEN, RM G J; Pedrazzoli, D; Bond, V; FOSTER, N; KRANZER, K;
2022
, PLOS Global Public Health (2022).
More treatment options for rifampicin-resistant tuberculosis: the role of economic evaluation in informing uptake.
SWEENEY, S; SINGH, MP;
2022
The Lancet Global Health, (2022).11 2 10.1016/S2214-109X(22)00519-8.